Skip to search formSkip to main contentSkip to account menu

ORM-12741

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzofuransQuinolizidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
A double-blind, randomized, placebo-controlled crossover trial of the α2C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis.
OBJECTIVES Our primary purpose was to evaluate the efficacy of the high-potency α2C-adrenoceptor antagonist ORM-12741 in the… 
2014
2014
A double-blind , randomized , placebo-controlled crossover trial of the a 2 C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis
Objectives. Our primary purpose was to evaluate the efficacy of the high-potency a2C-adrenoceptor antagonist ORM-12741 in the… 
Review
2013
Review
2013
Safety and efficacy of ORM-12741 on cognitive and behavioral symptoms in patients with Alzheimer's disease: A randomized, double-blind, proof-of-concept study
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)